TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Dysphagia Outcome and Severity Scale (DOSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of red blood cell micro particles (CD235)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Detection of leukocyte micro particles (CD45)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Detection of platelet micro particles (CD41)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Usability of mobile app
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Count of employees indicating interest in the booster
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Quick DASH form
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Hematoma assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Pain assessment using Wong Baker Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart Failure Hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Biochemically validated 7-day PPA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of psychological distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Predicted risk of lymph-node involvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Accuracy of glucose measurement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to achieve patient stabilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: A1C concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Dentoskeletal mandible changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lower incisor angle changes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reversibility of pre-diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in spatial-temporal deformation fields
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Absence of post-operative symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Performance of the implantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: LDL apoB turnover rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of endocrine organs involved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Area Under the Concentration versus time curve (AUC0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration versus time curve (AUC0-∞)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive Function Composite Score (ADAS-Cog-Exe)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Number of subjects free from device-related infection
Endpoint domain: Adverse events/effects
Primary endpoint: Secondary Patency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Ultrasound Diathermy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-operative extrusion rates of the ball implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Fasting blood glucose (FBG mg/dl)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glycated hemoglobin (HbA1C%)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting insulin (mU/L)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: maximum fundamental frequency of the cry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: positive predictive rate of tissue fluorescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Non-inferiority of subcutaneous isatuximab compared to intravenous isatuximab
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in bradykinesia features
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Changes in motor learning performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Humoral immunogenicity
Endpoint domain: Physiological/clinical
Primary endpoint: AUC0-24h,sema,ss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC0-24h,dapa,ss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reproducibility of swallowing assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinical data related to treatment efficacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: maintenance of deep NMB
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient Experience Scores
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Freedom from Target Lesion Failure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Numbers and percentage of participants with immediate adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Geometric mean titres (GMTs) of SARS-CoV-2-specific serum neutralising antibody
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of participants who achieved a greater than or equal to 4-fold rise in SARS-CoV-2-specific serum neutralising antibody titres
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentage of Subjects With Anti-PRP Antibody Concentrations ≥ 5 µg/mL at Month 11
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Need for benzodiazepines (daily use in mg)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Fibromyalgia Survey Criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-prandial lipemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Observer-Reported Communication Ability Measure (ORCA)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Patient enrollment and treatment-specific retention rates
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: bladder function change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Confirmed penicillin allergy
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of psychomotor disadaptation syndrome
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of Participants Recruited
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Number of Participants Who Maintain Adherence to at Least Daily Daily Breathing Awareness Meditation Sessions
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Meal test response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Clinical severity and recovery 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Clinical severity and recovery 2
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence of recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Work engagement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Psychological capital (PsyCap)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Strengths use
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Strengths identification, use and development
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Area size response to histamine and local heating
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Axon-reflex flare responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total number of neutrophils and early myeloid derived suppressor cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Renal parenchymal damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Total Vascular Density of sublingual microcirculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Microvascular Flow Index (MFI) of sublingual microcirculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Small Vessel Density of sublingual microcirculation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Area under drug time curve (AUC 0-t)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under drug time curve (AUC 0-last)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of days spent outside the hospital
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Incidents of Treatment-Emergent Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Incidents of participants with laboratory abnormality
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of OWL-EVO1 probe
Endpoint domain: Adverse events/effects
Primary endpoint: Percent of participants with at least 2 out of 3 assessments marked more than half the time on compliance questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of change in albuminuria (urine ACR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Score on Modified Barium Swallow Impairment Profile (MBSImP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in cognitive functions measured with Mindmore
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Grade of self-reported mental fatigue
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Blood plasma concentrations of Apixaban
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Negative symptoms: clinician-rated
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Real-world social interactions
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Motor evoked potentials amplitude and latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reaction time to startle response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: F-wave response persistence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: blood level of anti-S1 / RBD antibodies
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Temperature of acupoint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall Response Rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Accuracy of MRI measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Number of Patients Prescribed Appropriate Anticoagulation
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: FACIT-PAL 14
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Physician overall satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Patient/Caregiver overall satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Maximum number of repetitions possible
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Toxicity Index for GI, GU, Dermatologic, and Hematologic events
Endpoint domain: Adverse events/effects
Primary endpoint: Patient reported GI toxicity using PRO-CTCAE Diarrhea
Endpoint domain: Adverse events/effects
Primary endpoint: Last HbA1c
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time in Range (%TIR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean glucose (mg/dL)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Genetic diagnosis rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Life's Essential 8 Composite Score change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Blood Pressure Score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fasting Glucose/Hemoglobin A1c Score Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fugl-Meyer Assessment - Upper Extremity Scores (FMA-UE)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Preventive Oral Examinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with predictive EEG measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Self-reported anxiety scores of CARERS programme participants
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-reported depression scores of CARERS programme participants
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self-reported dementia knowledge scores of dementia programme participants
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perineal lacerations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Degree of Ecchymosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Degree of Edema
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Range of Motion at ankle joint
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Thwarted Belongingness
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Internal Coping Skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: External Coping Skills
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mean difference in HRQL score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduction in Epicardial adipose tissue volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total radioactivity in plasma PK:AUC0-t
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total radioactivity in plasma PK:t1/2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LXI-15028 and metabolite PK:Cmax
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of eligible individuals enrolled and retained
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Maximal isometric strength of knee extensors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Progression of valvular heart diseases
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Neuroprotective effects
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Feasibility of use of S-Press by patients
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Feasibility of use of S-Press by Healthcare Professionals
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: symptomatic SARS-CoV-2 infection
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of the Oncomagnetic device
Endpoint domain: Adverse events/effects
Primary endpoint: Diagnostic performance of 18F-MFBG PET
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Range of Motion (ROM) assessments
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H202 generation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TERT mitochondrial localization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proliferation in cells lines
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of achievement (success) of all four sections at the extremities
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Solicited Adverse Events (AEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of Unexpected Unacceptable Toxicities (UUT)
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of dose-limiting toxicity (DLT) events
Endpoint domain: Adverse events/effects
Primary endpoint: Changes in Beta-hCG Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Mean sweat volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biotin status
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Placental functional gene expression regulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson Fatigue Scale-16 (PFS-16)
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Hospital Anxiety and Depression Survey (HAD)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Parkinson's Disease Sleep Scale-2 (PDSS-2)
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: IOP Change
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Procedure-Related Major Complications
Endpoint domain: Adverse events/effects
Primary endpoint: Intracranial pressure (ICP) correlation with blood biomarkers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Relative abundance of gut microbiota
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall GO outcome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in rate of platelet aggregation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Device success at 7 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of slit2
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: accuracy of the structured light computer vision system
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depression Stigma
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attitude Towards Seeking Professional Psychological Help
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Rate of referral to tobacco treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Rate of engagement in tobacco treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of recurrent bleeding
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Genotype risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daily Depression Symptom Experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Daily Anxiety Symptom Experience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Core adequacy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of regimen-limiting toxicity (RLT)
Endpoint domain: Adverse events/effects
Primary endpoint: Dissection speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lesional damage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Subjective evaluation of the added value of the TRACMOTION device
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: The Oswestry Low Back Pain Disability Questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Joint Range of Motion Assessment (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxyhemoglobin (HbO) variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Deoxyhemoglobin (HbR) variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in Peak Force
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shear Wave Ultrasound Elastography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes